Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/CLC stock hub

CSE/CLC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/CLCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.4M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/CLC

In the news

Latest news · CSE/CLC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/E3.9

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/CLC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

CAD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 14.6M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA17104U1021
Last refreshed	2026-05-10
Market cap	CAD 7.4M
Price	CAD 0.03
Price currency	CAD
Sector	Healthcare
Sic	5159
Symbol	cse/CLC
Website	https://christinalakecannabis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	19.13%
EV Earnings	10.22x
EV/EBIT	4.09x
EV/EBITDA	3.96x
EV/FCF	-31.94x
EV/Sales	0.97x
FCF yield	-6.12%
P/B ratio	0.44x
P/E ratio	3.87x
P/S ratio	0.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.59%
EBITDA Margin	24.37%
Gross margin	46.47%
Gross Profit	CAD 7M
Gross Profit Growth	-23.02%
Gross Profit Growth Q	-48.6%
Gross Profit Growth3 Y	35.11%
Gross Profit Growth5 Y	8.02%
Net Income	CAD 1.4M
Net Income Growth	64.57%
Net Income Growth Q	-71.46%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	9.44%
Profit Margin	9.44%
Profitable Years	2
ROCE	16.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-33.35%
Cagr3y	-24.6%
Cagr5y	-44.89%
EPS Growth	17.71
EPS Growth Q	-83.67
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth	413.41%
OCF Growth3 Y	-1.43%
Revenue Growth	10.77x
Revenue Growth Q	16.44x
Revenue Growth Years	4x
Revenue Growth3 Y	14.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 28M
Cash	CAD 1.7M
Current Assets	CAD 17.2M
Current Liabilities	CAD 6.2M
Debt	CAD 8.8M
Debt EBITDA	CAD 2.39
Debt Equity	CAD 0.52
Debt FCF	CAD -19.26
Equity	CAD 16.8M
Interest Coverage	2.22
Liabilities	CAD 11.2M
Long Term Assets	CAD 10.8M
Long Term Liabilities	CAD 5M
Net Cash	CAD -7.1M
Net Cash By Market Cap	CAD -95.51
Net Debt EBITDA	CAD 1.94
Net Debt Equity	CAD 0.42
Tangible Book Value	CAD 16.8M
Tangible Book Value Per Share	CAD 0.07
WACC	7.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.76
Net Working Capital	CAD 13.1M
Quick ratio	0.46
Working Capital	CAD 11M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-39.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-33.33%
200-day SMA	0.04
3Y total return	-57.14%
50-day SMA	0.03
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.92%
All Time High	1.1
All Time High Change	-97.27%
All Time High Date	2021-01-25
All Time Low	0.02
All Time Low Change	100%
All Time Low Date	2023-07-04
ATR	0
Beta	-0.83
Beta1y	-0.54
Beta2y	-0.3
Ch YTD	-33.33
High	0.04
High52	0.06
High52 Date	2025-07-23
High52ch	-50%
Low	0.03
Low52	0.03
Low52 Date	2026-04-22
Low52ch	20%
Ma50ch	-11.76%
Price vs 200-day SMA	-29.58%
RSI	43.32
RSI Monthly	40.73
RSI Weekly	41.48
Sharpe ratio	1.03x
Sortino ratio	1.79
Total Return	-39.8%
Tr YTD	-33.33
Tr1w	-14.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 3.6M
Operating Income Growth	7.17
Operating Income Growth Q	-64.7
Operating margin	23.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	136,290,535%
Net Borrowing	-1,015,425
Shares Insiders	36%
Shares Institutions	0.91%
Shares Out	248,093,567
Shares Qo Q	-4.74%
Shares Yo Y	39.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -602,321
Average Volume	36,867x
Bv Per Share	0.07
CAPEX	CAD -1.6M
Ch1w	-14.29
Ch1y	-33.33
Ch3y	-57.14
Ch5y	-94.92
Ch6m	-14.29
Change	0%
Change From Open	0
Close	0.03
Days Gap	0
Depreciation Amortization	117,256
Dollar Volume	1,500
Earnings Date	2026-07-03
EBIT	CAD 3.6M
EBITDA	CAD 3.7M
EPS	CAD 0.01
F Score	4
FCF	CAD -455,638
FCF EV Yield	-3.13x
FCF Per Share	CAD -0
Financing CF	-239,425
Fiscal Year End	February
Founded	2,014
Graham Number	0.10884
Graham Upside	262.8
Investing CF	-1,542,098
Is Primary Listing	1
Last Earnings Date	2026-01-29
Last Report Date	2025-11-30
Ma150	0.04
Ma150ch	-24.43%
Ma20	0.03
Ma20ch	-4.76%
Net CF	-646,796
Next Earnings Date	2026-07-03
Open	0.03
P OCF Ratio	6.56
Position In Range	0
Ppne	9,793,375
Price Date	2026-05-08
Price EBITDA	CAD 2.03
Ptbv Ratio	0.44
Relative Volume	1.44x
Revenue	15,075,912x
SBC By Revenue	0.97x
Share Based Comp	146,683
Tr6m	-14.29%
Volume	50,000
Z Score	1.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/CLC pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/CLC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/CLC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.9%

Share of float held by funds and institutions

Insider ownership

+36.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+39.8%

Negative means the company is buying back shares.

Technical

CSE/CLC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.3

Neutral momentum band

Price vs 200-day MA

-29.6%

50/200-day relationship not available

Beta (5Y)

-0.83

Less volatile than the market

Sharpe ratio

1.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/CLC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/CLC stock rating?

cse/CLC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/CLC analysis?

The full report lives at /stocks/cse/CLC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/CLC?

The latest report frames cse/CLC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/CLC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.